Light-activated drug shows promise for fighting psoriasis
Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...
Science Daily2d
A light-activated drug to fight psoriasis
Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...
Daily23h
Younger Psoriasis Patients More Likely to Stop TNFi, Older Patients Face Adverse Events: Study From BADBIR
The study revealed that younger patients (16-24 years) with moderate-to-severe psoriasis were more likely to discontinue TNF ...
dermatologyadvisor22h
Drug Survival in Psoriasis Affected by Age at Initiation, Biologic Therapy Type
Age at initiation of treatment and the type of biologic therapy prescribed effect the rate of drug survival among patients with psoriasis.
tbsnews9h
Cold weather worsens symptoms of chronic illnesses, experts warn
Many people with ongoing medical conditions experience more symptoms during the winter. Here's why, and what you can do.
Healio2d
Latine patients with psoriasis report unique cultural, ethnic experiences in US
Published results showed “Latine” patients with psoriasis in the U.S. have unique experiences with their disease and ...
Pharmaceutical Technology2d
Vanda and AnaptysBio link for generalised pustular psoriasis therapy
Vanda and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise imsidolimab to ...
Too Old to Operate2d
The Link Between Psoriasis Risk & Life’s Essential 8
Higher cardiovascular health scores on Life’s Essential 8 were linked to a significantly lower risk for psoriasis in a large, ...
Armed robbery in Revesby3d
Light-activated Drug To Fight Psoriasis Presented
A study with the involvement of the UAB presents a new efficient photopharmaceutical drug to treat psoriasis and reduce the adverse effects associated ...